Coagulopathies in the PICU DIC and Liver Disease

被引:13
作者
Parker, Robert I. [1 ]
机构
[1] SUNY Stony Brook, Sch Med, Stony Brook Long Isl Childrens Hosp, Stony Brook, NY 11794 USA
关键词
Coagulopathy; Disseminated intravascular coagulation; Pediatric intensive care unit; Liver disease; RECOMBINANT-FACTOR-VIIA; DISSEMINATED INTRAVASCULAR COAGULATION; ACTIVATED FACTOR-VII; TISSUE-PLASMINOGEN ACTIVATOR; 4G/5G PROMOTER POLYMORPHISM; OFF-LABEL USE; PROTEIN-C; PLASMINOGEN-ACTIVATOR-INHIBITOR-1; GENE; FIBRINOLYTIC CAPACITY; ORGAN DYSFUNCTION;
D O I
10.1016/j.ccc.2012.12.003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Coagulopathies in the PICU: DIC and Liver Disease Robert I. Parker Bleeding in patients in pediatric intensive care units is associated with an increased risk of mortality. Fortunately, most patients with an abnormal coagulation profile do not bleed because this is generally secondary to liver disease or dietary-induced vitamin K deficiency. When the laboratory markers of coagulopathy are the result of disseminated intravascular coagulation, bleeding is common and the risk of mortality extreme. Although interventions directed toward correcting the abnormal coagulation test results are generally initiated, they are also generally either not warranted or not fully successful.
引用
收藏
页码:319 / +
页数:17
相关论文
共 62 条
[1]  
Afshari A, 2011, DAN MED BULL, V58
[2]   Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? [J].
Al Ghumlas, AK ;
Gader, AGMA ;
Al Faleh, FZ .
BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (05) :329-335
[3]   Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation [J].
Altman, R. ;
Scazziota, A. ;
De Lourdes Herrera, M. ;
Gonzalez, C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) :2022-2027
[4]  
Bick RL, 1999, HAEMOSTASIS, V29, P111
[5]   Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials [J].
Boffard, KD ;
Riou, B ;
Warren, B ;
Choong, PIT ;
Rizoli, S ;
Rossaint, R ;
Axelsen, M ;
Kluger, Y .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01) :8-16
[6]   Oral anticoagulation therapy in children [J].
Bonduel, Mariana M. .
THROMBOSIS RESEARCH, 2006, 118 (01) :85-94
[7]   Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage [J].
Brady, Kenneth M. ;
Easley, R. Blaine ;
Tobias, Joseph D. .
PEDIATRIC ANESTHESIA, 2006, 16 (10) :1042-1046
[8]   Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital-meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation [J].
Cauchie, Ph. ;
Cauchie, Ch. ;
Boudjeltia, K. Zouaoui ;
Carlier, E. ;
Deschepper, N. ;
Govaerts, D. ;
Migaud-Fressart, M. ;
Woodhams, B. ;
Brohée, D. .
AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (06) :414-419
[9]   Prophylactic Activated Recombinant Factor VII in Liver Resection and Liver Transplantation: Systematic Review and Meta-Analysis [J].
Chavez-Tapia, Norberto C. ;
Alfaro-Lara, Roberto ;
Tellez-Avila, Felix ;
Barrientos-Gutierrez, Tonatiuh ;
Gonzalez-Chon, Octavio ;
Mendez-Sanchez, Nahum ;
Uribe, Misael .
PLOS ONE, 2011, 6 (07)
[10]  
Chuansumrit A, 1999, J Med Assoc Thai, V82 Suppl 1, pS63